Dr. James D. K. Goteh, a Registered Pharmacist, currently serves as Director of the Pharmacovigilance & Clinical Trials Department for the Liberia Medicines and Health Products Regulatory Authority.
Dr. Goteh has many years of the experience of work in this field and represented Liberia at many international meetings and conferences. He is one of the Authors of the Pharmacovigilance and Clinical Trial Guidelines respectively. Dr. Goteh is also a Co-authors for the publication titled “ Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia”
He is a graduate of the Cutington University with a Bachelor of Science Degree in Biology (B.Sc.) and the School of Pharmacy, University of Liberia with a Bachelor of Pharmacy Degree (B-Pharm.) in 2003 and 2011 respectively. Dr. Goteh also graduated from the University of Benin, Nigeria with a Doctor of Pharmacy Degree (PharmD).
In addition to his academic and work-related achievements, Pharm. Dr. Goteh has participated in several pharmaceutical related international workshops/trainings (local and international). From these workshops and trainings, he has obtained certificates in the following areas: Bioequivalent/Bioavailability, Pharmacovigilance courses (Modules I & II), Clinical Trials, Financial and Project Management, etc.
Dr. Goteh is a member and had served as Secretary General and Vice President of the Pharmaceutical Association of Liberia (PAL), respectively. He has also served as a member of the West African Health Organization (WAHO) Expert Working Group on Clinical Trials, Pharmacovigilance and Post Market Surveillance for the West African Medicines Regulation Harmonization Project as well as a member of the International Society of Pharmacovigilance (ISoP).
Dr. Goteh has worked as a Classroom Teacher of the Dolokelen Gboveh High School and William Booth Junior & Senior High School of the Salvation Army School System in Liberia respectively.
As a Pharmacist, he has also worked as Medicine Dossiers Evaluator, Clinical Trial Protocols Reviewer, Trainer of healthcare Workers, Pharmacovigilance & Clinical Research of the Liberia Medicines and Health Products Regulatory Authority (LMHRA) since 2011.
Dr. Nuku B. Williams is a registered Liberian Pharmacist currently serving as the Deputy Director for Pharmacovigilance and Clinical Trial for the Authority.
Dr. Nuku B. Williams obtained Doctor of Pharmacy (PharmD) from the University of Benin (UNIBEN), Nigeria; Bachelor of Pharmacy (BPharm), School of Pharmacy, University of Liberia; Bachelor of Science (B.Sc.) in Biology and Chemistry from TJR Faulkner College of Science and Technology of the University of Liberia and a graduate from the Haywood Mission High School.
Dr. Nuku B. Williams have worked for the Authority for the past eight (8) years in various positions: prior to serving as Deputy Director for PV, he served as Manager for Premises Licensing from 2012 to 2015 and Deputy Director for the Inspectorate and Post Market Surveillance from 2015 to 2019.
Dr. Nuku B. Williams received several trainings Professional Regulator with many local and international institutions, including hands-on GMP Training on entrance Pharmaceutical Company in Ghana, as well as received certification in the following:
As enshrined in Part III, Count 5 of the LMHRA Act, the Authority is charged with the responsibility to conduct or facilitate necessary research and development, promote Pharmacovigilance, and disseminate timely drug information.
The Pharmacovigilance (PV) Unit is established to monitor the safety of all medicines and health products in Liberia and to share these reports with the international body. In 2013, the LMHRA met the basic requirements of the World Health Organization (WHO) International Drug Monitoring Program thereby becoming the 112th Official Member and at the same time gained the status of a National Pharmacovigilance Center (NPC).
The guideline for the National Pharmacovigilance System in Liberia has been developed to complement and support the efforts of educating all healthcare workers on this important concept and enhance their efforts in ensuring that safe, efficacious and quality medicines are made available to the entire Liberian populace.
Roll out Adverse Drug Reaction (ADR) forms to various health facilities and conduct training for health care workers in adverse drug reporting.
Coordinate with other health programs including the Expanded Program for Immunization (EPI), National AIDS Control Program (NACP) and other vertical programs to collect ADR reports
Report to the World Health Organization (WHO) International Drug Monitoring Program